DGWPF Stock Chart & Stats
$95.82
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$62.89 - $112.55
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.00
Market Cap
$1.75B
Enterprise Value$1.53B
Total Cash (Recent Filing)$198.46M
Total Debt (Recent Filing)$388.38M
Price to Earnings (P/E)10.5
Beta0.54
Next Earnings
Oct 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.56%
Share Statistics
EPS (TTM)9.14
Shares Outstanding10,160,000
10 Day Avg. Volume30
30 Day Avg. Volume13
Financial Highlights & Ratios
PEG Ratio0.74
Price to Book (P/B)0.80
Price to Sales (P/S)0.37
P/FCF Ratio7.81
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue0.43
Enterprise Value/Gross Profit0.93
Enterprise Value/Ebitda3.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.15
Revenue Forecast (FY)$4.09B
Bulls Say, Bears Say
Bulls Say
Improving Revenue And ProfitabilityBroad-based improvement in sales, EBIT and gross margin indicates stronger operating execution rather than growth confined to one product. If sustained, better profitability can support investment, strengthen resilience, and create a firmer earnings base over the next several quarters.
Safety Division Growth And MarginsSafety is showing durable commercial momentum alongside meaningful margin expansion, suggesting strong demand for detection and respiratory-protection solutions. Its improved profitability provides an important earnings anchor while the Medical segment continues its recovery.
Stronger Cash Flow And Balance SheetMeaningfully positive free cash flow and moderate leverage improve Dräger’s capacity to fund product development, service activity and working-capital needs internally. This financial flexibility also reduces dependence on external funding if operating conditions become less favorable.
Bears Say
Medical Segment Remains Loss-making In H1Medical has improved materially but has not yet restored consistent first-half profitability, leaving group earnings dependent on Safety and further execution gains. Continued losses or weaker orders could delay margin recovery and reduce the benefits of Dräger’s healthcare franchise.
Rising Operating And Freight CostsCost growth is running against the objective of expanding margins and could absorb part of the benefit from higher sales. Personnel and freight pressure may require pricing, productivity or spending actions, creating an ongoing risk to the sustainability of recent profitability gains.
Uneven Earnings And Cash ConversionThe recovery is encouraging, but the history of negative cash flow and weak profitability shows that earnings can be sensitive to operating conditions and cash requirements. This variability makes future funding capacity and margin durability less predictable than current results alone suggest.
DGWPF FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
Draegerwerk AG & Co. KGaA lowest stock price was $62.89 and its highest was $112.55 in the past 12 months.
What is Draegerwerk AG & Co. KGaA’s market cap?
Draegerwerk AG & Co. KGaA’s market cap is $1.75B.
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
Draegerwerk AG & Co. KGaA’s upcoming earnings report date is Oct 29, 2026 which is in 9 days.
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Draegerwerk AG & Co. KGaA released its earnings results on Jul 30, 2026. The company reported $1.774 earnings per share for the quarter.
Is Draegerwerk AG & Co. KGaA overvalued?
According to Wall Street analysts Draegerwerk AG & Co. KGaA’s price is currently Undervalued.
Does Draegerwerk AG & Co. KGaA pay dividends?
Draegerwerk AG & Co. KGaA pays a Annually dividend of $2.593 which represents an annual dividend yield of 2.56%. See more information on Draegerwerk AG & Co. KGaA dividends here
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
Draegerwerk AG & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
Draegerwerk AG & Co. KGaA has 10,160,000 shares outstanding.
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Draegerwerk AG & Co. KGaA reported an EPS of $1.774 in its last earnings report. Following the earnings report the stock price went up 7.02%.
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
Currently, no hedge funds are holding shares in DGWPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Draegerwerk AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.35%
12-Months-Change
Fundamentals
Return on Equity
10.62%
Trailing 12-Months
Asset Growth
6.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Draegerwerk AG & Co. KGaA
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is a global provider of advanced medical and safety technology solutions. The company serves a diverse international clientele across Europe, the Americas, Africa, Asia, and Australia. Within the medical field, Drägerwerk develops and markets comprehensive system solutions, equipment, and support services tailored for acute care environments. This encompasses emergency services, surgical procedures (perioperative care), intensive care units (critical care), and specialized newborn care (perinatal care). Their extensive product portfolio includes items such as anesthesia machines, respiratory ventilators, temperature management devices, monitoring systems for patients, and associated software and consumables. For safety applications, the company delivers essential products, integrated systems, and services designed for personal protection, sophisticated gas detection, and holistic hazard management. These offerings cater to industrial and mining operations, as well as public safety organizations like fire brigades, police forces, and disaster relief agencies. Key safety products range from fixed and portable gas sensing equipment to personal protective gear and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs, comprehensive service packages, and even dedicated fire training facilities for emergency responders.
Technical Analysis
Carl Zeiss Meditec
―
Eckert & Ziegler Strahlen und Medizintechnik
―
MeVis Medical Solutions
―
STRATEC Biomedical
―
Siemens Healthineers AG
―
Ownership Overview
―
Insiders
1.66% Mutual Funds
― Other Institutional Investors
98.19% Public Companies and
Individual Investors